Variability in the immune system: Of vaccine responses and immune states

Current Opinion in Immunology

Volumn 25, Issue 4, 2013, Pages 542-547

  Shen Orr, Shai S ^a   Furman, David ^b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE IV; CYTOKINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INFLUENZA VACCINE; MYELOID DIFFERENTIATION FACTOR 88; NEUTRALIZING ANTIBODY; SINGLE STRANDED RNA; TOLL LIKE RECEPTOR 7; UNCLASSIFIED DRUG; VACCINE; YELLOW FEVER VACCINE; YF 17D;

AGE DISTRIBUTION; AGING; ANTIBODY RESPONSE; ANTIBODY TITER; CD4 CD8 RATIO; COMPLEMENT SYSTEM; DISEASE PREDISPOSITION; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; GENE CONTROL; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNE STATUS; IMMUNE SYSTEM; IMMUNITY; IMMUNOGENETICS; IMMUNOLOGICAL PARAMETERS; IMMUNOPHENOTYPING; INFLUENZA VACCINATION; INNATE IMMUNITY; MOLECULAR MECHANICS; NONHUMAN; POPULATION RECOVERY; REVIEW; SEASONAL INFLUENZA; SIGNAL TRANSDUCTION; VACCINATION; VACCINE FAILURE;

AGING; HUMANS; IMMUNE SYSTEM; VACCINATION; VACCINES;

EID: 84884140862     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2013.07.009     Document Type: Review

References (51)

1. Oxman M.N., Levin M.J., Johnson G.R., Schmader K.E., Straus S.E., Gelb L.D., Arbeit R.D., Simberkoff M.S., Gershon A.A., Davis L.E., et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005, 352:2271-2284.
2. Schmader K.E., Levin M.J., Gnann J.W., McNeil S.A., Vesikari T., Betts R.F., Keay S., Stek J.E., Bundick N.D., Su S.C., et al. Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years. Clin Infect Dis 2012, 54:922-928.
3. Goodwin K., Viboud C., Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006, 24:1159-1169.
4. 23F among elderly individuals consists predominantly of switched memory B cells. J Infect Dis 2013, 208:101-108.
5. Wang C., Krishnakumar S., Wilhelmy J., Babrzadeh F., Stepanyan L., Su L.F., Levinson D., Fernandez-Vina M.A., Davis R.W., Davis M.M., et al. High-throughput, high-fidelity HLA genotyping with deep sequencing. Proc Natl Acad Sci U S A 2012, 109:8676-8681.
6. Maecker H.T., Lindstrom T.M., Robinson W.H., Utz P.J., Hale M., Boyd S.D., Shen-Orr S.S., Fathman C.G. New tools for classification and monitoring of autoimmune diseases. Nat Rev Rheumatol 2012, 8:317-328.
7. Jiang N., He J., Weinstein J.A., Penland L., Sasaki S., He X.S., Dekker C.L., Zheng N.Y., Huang M., Sullivan M., et al. Lineage structure of the human antibody repertoire in response to influenza vaccination. Sci Transl Med 2013, 5:171ra119.
8. Soon W.W., Hariharan M., Snyder M.P. High-throughput sequencing for biology and medicine. Mol Syst Biol 2013, 9:640.
9. Gaucher D., Therrien R., Kettaf N., Angermann B.R., Boucher G., Filali-Mouhim A., Moser J.M., Mehta R.S., Drake D.R., Castro E., et al. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J Exp Med 2008, 205:3119-3131.
10. Querec T.D., Akondy R.S., Lee E.K., Cao W., Nakaya H.I., Teuwen D., Pirani A., Gernert K., Deng J., Marzolf B., et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat Immunol 2009, 10:116-125.
11. Monath T.P. Yellow fever vaccine. Vaccines 2004, 1095-1176. WB Saunders, Philadelphia. S. Plotkin, W. Orenstein (Eds.).
12. Klein S.L., Jedlicka A., Pekosz A. The Xs and Y of immune responses to viral vaccines. Lancet Infect Dis 2010, 10:338-349.
13. Pennell L.M., Galligan C.L., Fish E.N. Sex affects immunity. J Autoimmun 2012, 38:J282-J291.
14. Fish E.N. The X-files in immunity: sex-based differences predispose immune responses. Nat Rev Immunol 2008, 8:737-744.
15. Cook I.F. Sexual dimorphism of humoral immunity with human vaccines. Vaccine 2008, 26:3551-3555.
16. Consortium THIP: Human Immunology Project Consortium 2013.
17. Inflammation CfHIAa: Center for Human Immunology Autoimmunity and Inflammation 2013.
18. Nakaya H.I., Wrammert J., Lee E.K., Racioppi L., Marie-Kunze S., Haining W.N., Means A.R., Kasturi S.P., Khan N., Li G.M., et al. Systems biology of vaccination for seasonal influenza in humans. Nat Immunol 2011, 12:786-795.
19. Furman D., Jojic V., Kidd B., Shen-Orr S., Price J., Jarrell J., Tse T., Huang H., Lund P., Maecker H.T., et al. Apoptosis and other immune biomarkers predict influenza vaccine responsiveness. Mol Syst Biol 2013, 9:659.
20. Obermoser G., Presnell S., Domico K., Xu H., Wang Y., Anguiano E., Thompson-Snipes L., Ranganathan R., Zeitner B., Bjork A., et al. Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines. Immunity 2013, 38:831-844.
21. Bucasas K.L., Franco L.M., Shaw C.A., Bray M.S., Wells J.M., Nino D., Arden N., Quarles J.M., Couch R.B., Belmont J.W. Early patterns of gene expression correlate with the humoral immune response to influenza vaccination in humans. J Infect Dis 2011, 203:921-929.
22. Zak D.E., Andersen-Nissen E., Peterson E.R., Sato A., Hamilton M.K., Borgerding J., Krishnamurty A.T., Chang J.T., Adams D.J., Hensley T.R., et al. Merck Ad5/HIV induces broad innate immune activation that predicts CD8(+) T-cell responses but is attenuated by preexisting Ad5 immunity. Proc Natl Acad Sci U S A 2012, 109:E3503-E3512.
23. Kennedy R.B., Oberg A.L., Ovsyannikova I.G., Haralambieva I.H., Grill D., Poland G.A. Transcriptomic profiles of high and low antibody responders to smallpox vaccine. Genes Immun 2013, 14:277-285.
24. Haralambieva I.H., Oberg A.L., Ovsyannikova I.G., Kennedy R.B., Grill D.E., Middha S., Bot B.M., Wang V.W., Smith D.I., Jacobson R.M., et al. Genome-wide characterization of transcriptional patterns in high and low antibody responders to rubella vaccination. PLoS ONE 2013, 8:e62149.
25. Haralambieva I.H., Oberg A.L., Dhiman N., Ovsyannikova I.G., Kennedy R.B., Grill D.E., Jacobson R.M., Poland G.A. High-dimensional gene expression profiling studies in high and low responders to primary smallpox vaccination. J Infect Dis 2012, 206:1512-1520.
26. Krebs J., Wilson A., Kisielow P. Calmodulin-dependent protein kinase IV during T-cell development. Biochem Biophys Res Commun 1997, 241:383-389.
27. Anderson K.A., Means A.R. Defective signaling in a subpopulation of CD4(+) T cells in the absence of Ca(2+)/calmodulin-dependent protein kinase IV. Mol Cell Biol 2002, 22:23-29.
28. Illario M., Giardino-Torchia M.L., Sankar U., Ribar T.J., Galgani M., Vitiello L., Masci A.M., Bertani F.R., Ciaglia E., Astone D., et al. Calmodulin-dependent kinase IV links Toll-like receptor 4 signaling with survival pathway of activated dendritic cells. Blood 2008, 111:723-731.
29. Kitsos C.M., Sankar U., Illario M., Colomer-Font J.M., Duncan A.W., Ribar T.J., Reya T., Means A.R. Calmodulin-dependent protein kinase IV regulates hematopoietic stem cell maintenance. J Biol Chem 2005, 280:33101-33108.
30. Karrer U., Sierro S., Wagner M., Oxenius A., Hengel H., Koszinowski U.H., Phillips R.E., Klenerman P. Memory inflation: continuous accumulation of antiviral CD8+ T cells over time. J Immunol 2003, 170:2022-2029.
31. Virgin H.W., Wherry E.J., Ahmed R. Redefining chronic viral infection. Cell 2009, 138:30-50.
32. Stiasny K., Aberle J.H., Keller M., Grubeck-Loebenstein B., Heinz F.X. Age affects quantity but not quality of antibody responses after vaccination with an inactivated flavivirus vaccine against tick-borne encephalitis. PLoS ONE 2012, 7:e34145.
33. Khan N., Shariff N., Cobbold M., Bruton R., Ainsworth J.A., Sinclair A.J., Nayak L., Moss P.A. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol 2002, 169:1984-1992.
34. Gibson K.L., Wu Y.C., Barnett Y., Duggan O., Vaughan R., Kondeatis E., Nilsson B.O., Wikby A., Kipling D., Dunn-Walters D.K. B-cell diversity decreases in old age and is correlated with poor health status. Aging Cell 2009, 8:18-25.
35. Effros R.B., Boucher N., Porter V., Zhu X., Spaulding C., Walford R.L., Kronenberg M., Cohen D., Schachter F. Decline in CD28+ T cells in centenarians and in long-term T cell cultures: a possible cause for both in vivo and in vitro immunosenescence. Exp Gerontol 1994, 29:601-609.
36. Comin F., Speziali E., Martins-Filho O.A., Caldas I.R., Moura V., Gazzinelli A., Correa-Oliveira R., Faria A.M. Ageing and Toll-like receptor expression by innate immune cells in chronic human schistosomiasis. Clin Exp Immunol 2007, 149:274-284.
37. Buffa S., Bulati M., Pellicano M., Dunn-Walters D.K., Wu Y.C., Candore G., Vitello S., Caruso C., Colonna-Romano G. B cell immunosenescence: different features of naive and memory B cells in elderly. Biogerontology 2011, 12:473-483.
38. Hoffmann J., Spyridopoulos I. Telomere length in cardiovascular disease: new challenges in measuring this marker of cardiovascular aging. Fut Cardiol 2011, 7:789-803.
39. Bergman A., Atzmon G., Ye K., MacCarthy T., Barzilai N. Buffering mechanisms in aging: a systems approach toward uncovering the genetic component of aging. PLoS Comput Biol 2007, 3:e170.
40. Evans D.M., Frazer I.H., Martin N.G. Genetic and environmental causes of variation in basal levels of blood cells. Twin Res: Off J Int Soc Twin Stud 1999, 2:250-257.
41. de Maat M.P., Bladbjerg E.M., Hjelmborg J., Bathum L., Jespersen J., Christensen K. Genetic influence on inflammation variables in the elderly. Arterioscler Thromb Vasc Biol 2004, 24:2168-2173.
42. Grundberg E., Small K.S., Hedman A.K., Nica A.C., Buil A., Keildson S., Bell J.T., Yang T.P., Meduri E., Barrett A., et al. Mapping cis- and trans-regulatory effects across multiple tissues in twins. Nat Genet 2012, 44:1084-1089.
43. Liu Y., Aryee M.J., Padyukov L., Fallin M.D., Hesselberg E., Runarsson A., Reinius L., Acevedo N., Taub M., Ronninger M., et al. Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis. Nat Biotechnol 2013, 31:142-147.
44. Wikby A., Maxson P., Olsson J., Johansson B., Ferguson F.G. Changes in CD8 and CD4 lymphocyte subsets. T cell proliferation responses and non-survival in the very old: the Swedish longitudinal OCTO-immune study. Mech Ageing Dev 1998, 102:187-198.
45. Strindhall J., Skog M., Ernerudh J., Bengner M., Lofgren S., Matussek A., Nilsson B.O., Wikby A. The inverted CD4/CD8 ratio and associated parameters in 66-year-old individuals: the Swedish HEXA immune study. Age (Dordr) 2013, 35:985-991.
46. Olsson J., Wikby A., Johansson B., Lofgren S., Nilsson B.O., Ferguson F.G. Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech Ageing Dev 2000, 121:187-201.
47. Hadrup S.R., Strindhall J., Kollgaard T., Seremet T., Johansson B., Pawelec G., thor Straten P., Wikby A. Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly. J Immunol 2006, 176:2645-2653.
48. Ferguson F.G., Wikby A., Maxson P., Olsson J., Johansson B. Immune parameters in a longitudinal study of a very old population of Swedish people: a comparison between survivors and nonsurvivors. J Gerontol A: Biol Sci Med Sci 1995, 50:B378-B382.
49. Bar-Yam Y., Harmon D., de Bivort B. Systems biology. Attractors and democratic dynamics. Science 2009, 323:1016-1017.
50. Waddington C.H. Principles of Embryology 1956, Allen and Unwin, London.
51. Davis M.M. A prescription for human immunology. Immunity 2008, 29:835-838.